Number of items: 4.
Article
GLP-1 and dual GIP/GLP-1 receptor agonists’ psychopharmacology and putative neuropsychiatric associated effects: a Bradford Hill–informed, systematic, evaluation. (2026)
Fabrizio Schifano,
Maria Antonietta De Luca,
Stefania Bonaccorso,
Davide Arillotta,
Giuseppe Floresta,
Giovanni Martinotti,
Gabriele Duccio Papanti,
John Martin Corkery,
Stefania Chiappini
and
Amira Guirguis
picture_as_pdf
Psychoactive Synthetic Adulterants in Tablets Sold as MDMA after the COVID-19 Pandemic : Implications for Central Effects. (2026)
Maria Antonietta De Luca,
Cristina Miliano,
Amanda Roxburgh,
Myfanwy Graham,
Francesca Caria,
Amira Guirguis,
Fabrizio Schifano,
Suzanne Nielsen,
Nicola Simola
and
Giulia Costa
picture_as_pdf
Cannabis; epidemiological, neurobiological and psychopathological issues: an update. (2017)
Maria Antonietta De Luca,
Gaetano Di Chiara,
Cristina Cadoni,
Daniele Lecca,
Laura Orsolini,
Duccio Papanti,
John Corkery
and
Fabrizio Schifano
Native CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids : BB-22, 5F-PB-22, 5F-AKB-48 and STS-135. (2016)
Maria Antonietta De Luca,
M. Paola Castelli,
Barbara Loi,
Alessandra Porcu,
Mariella Martorelli,
Cristina Miliano,
Kathryn Kellett,
Colin Davidson,
Jacqueline L. Stair,
Fabrizio Schifano
and
Gaetano Di Chiara
This list was generated on Sun Oct 4 01:40:37 2026 BST.